APTAH Bioinformatics is a new innovative company in the field of drug discovery. Our mission is to provide the biotechnology and pharmaceutical industry with new oligonucleotides, while reducing the time, costs and risk of drug development and making new medicines widely available. APTAH has an own algorithm with which we are able to reduce the time, costs and risks of the discovery process of new synthetic and biological molecules based on DNA and RNA. This new computational modeling method (in silico) is a replacement for the SELEX process. Because of APTAH’s new algorithm it is possible to achieve the best connection to a specific target in a few days rather than months as is usual at the moment. APTAH Bioengineering is a virtual laboratory, everything is done using in silico methods rather than the expensive and time consuming in vitro methods that are most common. The algorithm ensures a good connection to the specific targets and thus reduces the risks in the discovery of new drugs. Our goal is to make new medicines faster and more widely available for an honest and accessible price.
Location: United States, California, San Carlos
Member count: 1-10
Phone: +1 650-732-6177
Total raised: $2.5M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 25.05.2021 | MBC BioLab... | mbcbiolabs... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 24.11.2020 | Seed | $2.5M | - | - |